Gaetano De Ferrari, MD, breaks down VESALIUS-CV findings on evolocumab and first MI prevention across major infarct subtypes.
Gaetano De Ferrari, MD
Advertisement
Gaetano De Ferrari, MD, is a professor and the Head of Cardiology at the University of Turin.
Articles by Gaetano De Ferrari, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
ESC Congress 2026: Day 1 Recap—5 Headlines to Know
2
2026 ESC Guidelines for Heart Failure Redefine Disease and Treatment Subtypes
3
Tirzepatide Gets FDA Approval to Cut Cardiovascular Risk in Type 2 Diabetes
4
Treating ATTR-CM With Urgency: How Strength in TTR Silencing Is Helping Change the Course of Patient Care
5